These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23881886)

  • 61. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recreational cannabinoid use: The hazards behind the "high".
    Wright S; Metts J
    J Fam Pract; 2016 Nov; 65(11):770-779. PubMed ID: 28087865
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes.
    Stiles BM; Fish AF; Cook CA; Silva V
    Perspect Psychiatr Care; 2016 Jan; 52(1):68-78. PubMed ID: 25624142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthetic Cannabinoid Use Among High School Seniors.
    Palamar JJ; Barratt MJ; Coney L; Martins SS
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28893851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabis-induced psychosis associated with high potency "wax dabs".
    Pierre JM; Gandal M; Son M
    Schizophr Res; 2016 Apr; 172(1-3):211-2. PubMed ID: 26876313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.
    Müller H; Sperling W; Köhrmann M; Huttner HB; Kornhuber J; Maler JM
    Schizophr Res; 2010 May; 118(1-3):309-10. PubMed ID: 20056392
    [No Abstract]   [Full Text] [Related]  

  • 70. Ischemic stroke after use of the synthetic marijuana "spice".
    Freeman MJ; Rose DZ; Myers MA; Gooch CL; Bozeman AC; Burgin WS
    Neurology; 2013 Dec; 81(24):2090-3. PubMed ID: 24212384
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthetic cannabinoid overdose in a 20-year-old male US soldier.
    Berry-Cabán CS; Ee J; Ingram V; Berry CE; Kim EH
    Subst Abus; 2013; 34(1):70-2. PubMed ID: 23327506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP).
    Cubells JF; Feinn R; Pearson D; Burda J; Tang Y; Farrer LA; Gelernter J; Kranzler HR
    Drug Alcohol Depend; 2005 Oct; 80(1):23-33. PubMed ID: 15894433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort.
    Stirling J; Barkus EJ; Nabosi L; Irshad S; Roemer G; Schreudergoidheijt B; Lewis S
    Psychopathology; 2008; 41(6):371-8. PubMed ID: 18787359
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spice: a legal marijuana equivalent.
    Johnson LA; Johnson RL; Alfonzo C
    Mil Med; 2011 Jun; 176(6):718-20. PubMed ID: 21702397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM; McIntosh AM; Lawrie SM
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cannabis use at a young age is associated with psychotic experiences.
    Schubart CD; van Gastel WA; Breetvelt EJ; Beetz SL; Ophoff RA; Sommer IE; Kahn RS; Boks MP
    Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics' ('Spice') Intake?
    Orsolini L; Papanti D; Corkery J; De Luca MA; Cadoni C; Di Chiara G; Schifano F
    CNS Neurol Disord Drug Targets; 2017; 16(5):585-591. PubMed ID: 28412917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical variants of psychoses in patients using synthetic cannabinoids (Spice)].
    Vinnikova MA; Skryabin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8):23-26. PubMed ID: 32929920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.